PulseAugur
中
实时 10:18:32
English(EN) ReMedI: Inference-Time Refinement and Self-Distillation for Controllable Molecular Optimization

新AI方法ReMedI增强药物先导优化

作者 PulseAugur 编辑部 · [1 个来源] ·

研究人员开发了ReMedI，一种用于药物开发中可控分子优化的新方法。该方法利用预训练的分子语言模型结合高效的Metropolis-Hastings搜索策略来精炼分子先导。ReMedI旨在在保持先导相似性的同时，改善渗透性等竞争性性质并降低毒性，在C-MuMOInstruct和SMDD等基准测试中表现优于现有基线。 AI

影响 该方法可以通过提高分子优化过程的效率和可控性来加速药物发现。

排序理由 该集群描述了一篇关于用于分子优化的新AI方法的最新研究论文。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.AI 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

新AI方法ReMedI增强药物先导优化

本文如何被排名

Signal score
13 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
该集群描述了一篇关于用于分子优化的新AI方法的最新研究论文。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, model release
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Same-day
Cluster formed today. Ranking reflects the current source set at time of score.

完整方法见我们的编辑标准。

报道来源 [1]

  1. arXiv cs.AI TIER_1 English(EN) · Jia Yi Zhang, Shivanshu Shekhar, Allison McLevige, Tong Zhang ·

    ReMedI：可控分子优化的推理时精炼与自蒸馏

    arXiv:2610.32103v1 Announce Type: cross Abstract: In drug development, lead optimization must improve competing properties, such as increasing permeability and reducing toxicity, while limiting scaffold changes that could compromise the lead's potency. RL-based post-training, suc…

相关实体

相关话题